Webcasts

***Available Now!*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*

***Live: Monday, March 29, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** In order to achieve the required sensitivity when working with small samples sizes, such as in the case of proteomic or metabolomic analysis, a low flow rate LC column is required. Micro and nano LC provides a practical solution for labs and along with the added advantage of core-shell particles, the sensitivity needs are exceeded. ***On Demand until Mar. 29, 2022***

*Thursday, March 25, 2021 at 10am EDT| 7am PDT| 2pm GMT| 3pm CET* Join us to learn how to address challenges with screening protein complexes using hydrogen–deuterium exchange and cyclic ion-mobility MS. *On demand available after final airing until March 25, 2022*

*Monday, March 22, 2021 at 9am EDT| 1pm GMT | 2pm CET, Monday, March 22, 2021 at 2pm EDT| 1pm CDT | 11am PDT* High resolution is one of the key challenges in modern biopharmaceutical analysis. In this webinar learn the importance of considering the entire liquid chromatography (LC) system to gain optimum results and maximum resolution from your LC column. *On demand available after final airing until March 22, 2022*

***Live: Wednesday March 17, 2021 at 11am EDT| 8am PDT| 4pm GMT| 5pm CET *** Single-use material selection is a crucial element of process development for bioprocessing, and emerging viral vector-based therapies have special requirements. Learn about efforts to better understand the relationship of single-use material selection and process impact to improve yield. ***On Demand until March 17, 2022***

***Live: Europe Broadcast: Tuesday, March 9, 2021 at 9am EST | 2pm GMT | 3pm CET US Broadcast: Tuesday, March 9, 2021 2pm EST | 1pm CST | 11am PST*** This event will aim to present an overview of how analytical technologies can be adapted for implementation of Process Analytical Technology (PAT) in bioprocessing and how this can result in effective process control, thereby delivering consistent process performance and product quality.

***Live: Wednesday, March 3, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET *** In this presentation we will demonstrate the gains in proteome characterization that can be achieved by using modern HPLC materials, both core–shell and full porous based. We will also show improvements that can be realized via selectivity optimization of not only the HPLC column chemistry but also trap chemistries when using a trap-and-elute workflow. .***On Demand until Mar. 3, 2022***

*Live Date: Tuesday, March 2, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET* In this webinar, you will learn how LC-MS has been broadly leveraged to accelerate the development of antibody-drug conjugates (ADCs). *Available On Demand Until March 2, 2022*

***Live: Wednesday, February 24, 2021 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** Do biologics aggregate in blood or serum? *On Demand until Feb. 24, 2022*

***Live: Tuesday, Feb. 23, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until Feb. 23, 2022*

***Live: Wednesday, January 20, 2021 at 11am EST | 8am PST | 4 pm GMT | 5pm CET *** Cell culture media (CCM) optimization is a critical step during the development and scale up of biotherapeutic manufacturing process. In particular, the emphasis on quality by design has made it necessary to understand how the components of CCM change during production and how these changes relate to product quality. In this webcast, learn how targeted cell-culture media workflow can help scientists understand growth media for biotherapeutics and improve their manufacturing process. ***On demand available after final airing until Jan. 20, 2022***

***Live: Tuesday, December 15, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** Nanopharmaceuticals: the latest in standardized methods for characterization and quantification ***On demand available after final airing until Dec. 15, 2021***

***Live: Thursday, Dec. 3, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** Review preclinical strategies to improve drug development outcomes for biologic drugs, including innovative solutions and risk-based approach to expedite investigational new drug submissions, especially for pandemic response initiatives.. ***On demand available after final airing until Dec. 3, 2021***

***Live: Wednesday, December 2, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Learn more about the recent trends in single-use sensors to match bioprocessing needs of bioreactor, fermenters, and mixing applications. Review data from 2-year studies of sensor testing.***On demand available after final airing until Dec. 2, 2021***

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021***

***Live: Friday, November 20, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET***Chemical characterization of medical device materials within a risk management process, addressed in ISO 10993 Part 18, was significantly revised in 2020. Part of this critical standard is to ascertain the extractables and leachables from a medical device to enable the estimation and control of biological risks. Join us for this webcast to learn about an LC–MS workflow to help address this challenge.***On demand available after final airing until NOV. 20, 2021***

***Live: Wednesday, November 18, 2020 at 10am EST | 9am CST | 3pm GMT | 4pm CET***Learn how automating mass spectrometry (MS)-based site-specific glycosylation monitoring of biotherapeutics can increase throughput and improving data quality in glycosylation monitoring of biotherapeutics.***On demand available after final airing until NOV. 18, 2021***

***Live: Tuesday, November 17, 2020 at 8am PST| 11am EST| 4pm GMT| 5pm CET***Shine a light on the (co-)formulation and stability one or more proteins.***On demand available after final airing until NOV. 17, 2021***

***Live: Tuesday, November 3, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** In this webcast, learn how multi-attribute assays were used to accelerate routine workflows for biotherapeutics characterization at the intact and subunit level. This new streamlined approach increased the efficiency to perform stability assessment of antibody-drug onjugates (ADC) significantly.***On demand available after final airing until Nov. 3, 2021***

*** Two Live Events! Monday, Oct. 26, 2020 at 9am EDT| 1pm GMT| 2pm CET and Monday, Oct. 26, 2020 at 2pm EDT| 1pm CDT| 11am PDT*** Join us for this web seminar to learn about the utility of mass spectrometry for characterizing adeno-associated viruses (AAVs), including how intact mass spectrometry can accurately confirm AAV capsid proteins, how AAV post-translational modifications can be identified and confirmed, and how upfront sample preparation can improve mass spec accuracy and resolution. ***On demand available after final airing until Oct. 26, 2021***

*** Three Events: Tuesday, Oct. 27, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET Asia Pacific: Wednesday, Oct. 28, 2020 at 10:30 am IST| 1pm CST| 2pm JST Europe: Wednesday, Oct. 28, 2020 at 9am| 10am CET*** Characterizing complex nanoparticles, polymers and biotherapeutics is about to get a lot easier. ***On demand available after final airing until Oct. 28, 2021***

***Live: Thursday, Oct. 22, 2020 at 10am EDT| 9am CDT| 3pm BST| 4pm CEST***Process development for anchorage-dependent cells at bench scale is crucial to establish cost-efficient workflows in larger volumes. Learn how different process parameter can be monitored and controlled in a perfusion bioprocess and the potential of using packed-bed bioreactors or a microcarrier spin filter for attachment cell-based vaccine production.. *** On demand available after final airing until Oct. 22, 2021.***

***Live: Wednesday, Oct. 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Host cell proteins (HCPs) can compromise a biologic drug and delay its development program. Learn about important considerations for optimizing HCP testing in this webcast. ***On demand available after final airing until Oct. 21, 2021***

***Live: Wednesday, Oct. 14, 2020, at 11am EDT| 8am PDT| 4pm BST| 5pm CEST*** Hear experts review key milestones and tasks—as well as potential stumbling blocks—along the drug development pathway and offer strategies to help discovery-phase drug development programs move from the lab to clinic and commercialization. *** On demand available after final airing until Oct. 14, 2021.***

Non-infectious mock virus particles that mimic the physicochemical properties of live infectious viruses can be used as spiking agents during viral clearance testing. Review results from several studies using an economical spiking surrogate—a non-infectious minute virus of mice-mock virus particle (MVM-MVP)—to demonstrate viral clearance in industrial processes. Tuesday, Oct 6, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after final airing until Oct. 6, 2021.

The cold chain distribution of biopharmaceutical products is hampered by product loss from brittle components and temperature excursions. Learn about a risk-mitigation strategy and study results that highlight the importance of choosing the right low-temperature materials, use sensors for monitoring the distribution process step, and testing to qualify a single-use cold chain solution. Monday, Oct. 12, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after final airing until Oct. 12, 2021.

Media fill tests ensure the safe production of parenteral drugs. Learn factors to consider when selecting media for aseptic process simulations including US and European regulatory requirements and eser requirement specifications for equipment and instruments. Tuesday Sept. 29, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing until Sept. 29, 2021.

Biopharmaceutical companies are transitioning from “quality-by-testing” philosophy to “quality-by-design” paradigms, and establishing QbD-based PAT tools to increase product and process understanding. Due to the deficit of analytical methods to support QbD-driven continuous bioprocessing, biopharmaceutical companies are actively developing PAT tools to comply with QbD regulations. Europe Broadcast: Wednesday, Sept. 30, 2020 at 9am EDT | 2pm BST | 3pm CEST US Broadcast: Wednesday, Sept. 30, 2020 at 2pm EDT | 1pm CDT | 11am PDT On demand available after final airing until Sept. 30, 2021.